![]() |
|
|
Vol. 294, Issue 1, 302-307, July 2000
Department of Pharmacology, Institute of Experimental Medicine,
Hungarian Academy of Sciences, Budapest, Hungary
The complex effect of lobeline on [3H]norepinephrine
([3H]NE) release was investigated in this study.
Lobeline-induced release of [3H]NE from the vas deferens
was strictly concentration-dependent. In contrast, electrical
stimulation-evoked release was characterized by diverse effects of
lobeline depending on the concentration used: at lower concentration
(10 µM), it increased the release and at high concentration (100 and
300 µM), the evoked release of [3H]NE was abolished.
The effect of lobeline on the basal release was
[Ca2+]-independent, insensitive to mecamylamine, a
nicotinic acetylcholine receptor antagonist, and to desipramine, a
noradrenaline uptake inhibitor. However, lobeline-induced release was
temperature-dependent: at low temperature (12°C), at which the
membrane carrier proteins are inhibited, lobeline failed to increase
the basal release. Lobeline dose dependently inhibited the uptake of
[3H]NE into rat hippocampal synaptic vesicles and
purified synaptosomes with IC50 values of 1.19 ± 0.11 and 6.53 ± 1.37 µM, respectively. Lobeline also inhibited
Ca2+ influx induced by KCl depolarization in sympathetic
neurons measured with the Fura-2 technique. In addition, phenylephrine,
an
1-adrenoceptor agonist, contracted the smooth muscle
of the vas deferens and enhanced stimulation-evoked contraction. Both
effects were inhibited by lobeline. Our results can be best explained
as a reversal of the monoamine uptake by lobeline that is facilitated
by the increased intracellular NE level after lobeline blocks vesicular
uptake. At high concentrations, lobeline acts as a nonselective
Ca2+ channel antagonist blocking pre- and postjunctional
Ca2+ channels serving as a counterbalance for the multiple
transmitter releasing actions.
This article has been cited by other articles:
![]() |
B. Lendvai and E. S. Vizi Nonsynaptic Chemical Transmission Through Nicotinic Acetylcholine Receptors Physiol Rev, April 1, 2008; 88(2): 333 - 349. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Papp, T. Balazsa, A. Kofalvi, F. Erdelyi, G. Szabo, E. S. Vizi, and B. Sperlagh P2X Receptor Activation Elicits Transporter-Mediated Noradrenaline Release from Rat Hippocampal Slices J. Pharmacol. Exp. Ther., September 1, 2004; 310(3): 973 - 980. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. K. Miller, P. A. Crooks, L. Teng, J. M. Witkin, P. Munzar, S. R. Goldberg, J. B. Acri, and L. P. Dwoskin Lobeline Inhibits the Neurochemical and Behavioral Effects of Amphetamine J. Pharmacol. Exp. Ther., March 1, 2001; 296(3): 1023 - 1034. [Abstract] [Full Text] |
||||